Pharmaceutical Compositions Containing Combined Platelet Aggregation Inhibiting Substances For Use In The Treatment And Prevention Of Ischemic Vascular Events

  • Published: Nov 19, 2008
  • Earliest Priority: Dec 20 2005
  • Family: 6
  • Cited Works: 1
  • Cited by: 0
  • Cites: 0
  • Additional Info:
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The invention relates to the pharmaceutical industry in general and in particular to the pharmaceutical industry involved in the production of medicaments for controlling and preventing ischemic vascular events. More specifically, the invention relates to a composition comprising a combination of platelet aggregation inhibiting substances. The composition is characterised in that the aforementioned combination or association consists of a selected platelet aggregation inhibiting substance known as Clopidogrel and a platelet aggregation inhibiting substance having hypolipidaemic activity, known as Policosanol, in order to produce a produce which has a synergistic effect for the prevention and treatment of ischemic vascular events.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Nov 19, 2008
  • Application: Jul 12, 2006
    EP EP 06783798 A
  • Priority: Jul 12, 2006
    MX MX 2006000068 W
  • Priority: Dec 20, 2005
    MX MX PA05014086 A

Download Citation


Sign in to the Lens

Feedback